Organon & Co

Financials

Genel Bakış Tablolar İstatistikler Temettüler

İşletme faaliyetlerinden elde edilen nakit 390 M75 M220 M264 M141 M 700 M Yatırım faaliyetlerinden elde edilen nakit -296 M-172 M-38 M-115 M-65 M -390 M Finansman faaliyetlerinden elde edilen nakit -82 M-75 M-223 M-76 M-187 M -561 M Free cash flow 303 M-12 M181 M149 M96 M 414 M

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

OGN

Financials

Organon & Co

Haberler

Organon (OGN) Stock Drops Despite Market Gains: Important Facts to Note

Organon Takeover At $15? Probably Not, Here's Why (NYSE:OGN)

Dow Dips Over 250 Points: Investor Sentiment Declines, Greed Index Remains In 'Fear' Zone - Goldman Sachs

Morning News Wrap-Up 4/10/26: Today’s Biggest Stock Market Stories! - TipRanks.com

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

Organon Jumps 25% As Report Cites $12 Billion Sun Pharma Offer

S&P Futures Waver With All Eyes on Key U.S. Inflation Data, U.S.-Iran Talks Awaited

Organon hisseleri Sun Pharma’nın 12 milyar dolarlık teklifi ile %8,4 yükseldi

Organon & Co hissesi 5,76 dolarla 52 haftalık dip yaptı

Organon, atopik dermatit için VTAMA krem verilerini AAD’de sundu

Organon & Co hissesi 6,17 dolarda 52 haftalık dip yaptı

Origin Enterprises 2026 ilk yarı sonuçları: Latin Amerika büyümeyi destekledi